Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic
- PMID: 27897918
- PMCID: PMC5592108
- DOI: 10.1080/08897077.2016.1264535
Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic
Abstract
Background: Opioid misuse and dependence are prevalent and rising problems in the United States. Treatment with buprenorphine is a successful treatment option for individuals with opioid dependence. This study describes and preliminarily evaluates a unique delivery system that provides buprenorphine treatment via a shared medical appointment.
Methods: A retrospective medical record review on all 77 opioid-dependent patients referred for a buprenorphine shared medical appointment in a homeless clinic from 2010 to 2012.
Results: Most patients were currently homeless (61%), unemployed (92%), had an Axis I psychiatric diagnosis (81%), and had recent polysubstance use (53%). Of the 77 patients, 95% attended at least 1 shared medical appointment. Treatment retention at 12 and 24 weeks was 86% and 70%, respectively.
Conclusions: In a patient population with complex social and mental health histories, buprenorphine treatment via a shared medical appointment had high retention rates. Findings can help guide the development of unique delivery systems to serve real-world complex patients with opioid dependence.
Keywords: Buprenorphine; group visit; homeless; office-based treatment; shared medical appointment.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Text message reminders for improving patient appointment adherence in an office-based buprenorphine program: A feasibility study.Am J Addict. 2017 Sep;26(6):581-586. doi: 10.1111/ajad.12557. Epub 2017 Aug 11. Am J Addict. 2017. PMID: 28799677
-
Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study.Subst Abus. 2015;36(2):166-9. doi: 10.1080/08897077.2014.998400. Subst Abus. 2015. PMID: 25738320
-
Using Shared Medical Appointments to Increase Access to Buprenorphine Treatment.J Am Board Fam Med. 2015 Sep-Oct;28(5):676-7. doi: 10.3122/jabfm.2015.05.150017. J Am Board Fam Med. 2015. PMID: 26355141
-
Buprenorphine Treatment for Opioid Use Disorder: An Overview.CNS Drugs. 2019 Jun;33(6):567-580. doi: 10.1007/s40263-019-00637-z. CNS Drugs. 2019. PMID: 31062259 Free PMC article. Review.
-
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update.Pharmacopsychiatry. 2021 Jan;54(1):18-22. doi: 10.1055/a-1298-4508. Epub 2020 Nov 19. Pharmacopsychiatry. 2021. PMID: 33212514 Review.
Cited by
-
Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts.JAMA Netw Open. 2024 Oct 1;7(10):e2437233. doi: 10.1001/jamanetworkopen.2024.37233. JAMA Netw Open. 2024. PMID: 39412807 Free PMC article.
-
"There's always somebody that you can identify with": a qualitative study of patient perspectives on buprenorphine group medical visits.Addict Sci Clin Pract. 2025 Feb 5;20(1):8. doi: 10.1186/s13722-025-00540-7. Addict Sci Clin Pract. 2025. PMID: 39910610 Free PMC article.
-
Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study.Ann Med. 2023 Dec;55(1):733-743. doi: 10.1080/07853890.2023.2182908. Ann Med. 2023. PMID: 36856571 Free PMC article.
-
Opioid use disorder treatment for people experiencing homelessness: A scoping review.Drug Alcohol Depend. 2021 Jul 1;224:108717. doi: 10.1016/j.drugalcdep.2021.108717. Epub 2021 Apr 20. Drug Alcohol Depend. 2021. PMID: 33985863 Free PMC article.
-
PROTOCOL: A comprehensive review of prioritized interventions to improve the health and wellbeing of persons with lived experience of homelessness.Campbell Syst Rev. 2019 Sep 12;15(3):e1048. doi: 10.1002/cl2.1048. eCollection 2019 Sep. Campbell Syst Rev. 2019. PMID: 37133294 Free PMC article. No abstract available.
References
-
- Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet. 2003;361(9358):662–8. - PubMed
-
- National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280(22):1936–43. - PubMed
-
- Fiellin DA, O'Connor PG. Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347(11):817–23. - PubMed
-
- Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349(10):949–58. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical